The pharmaceutical industry estimates President Donald Trump’s new drug pricing proposal could cost drug companies as much as $1 trillion over a decade, its largest trade group is telling members of ...
The Association for Accessible Medicines (AAM) has issued a white paper urging the US Food and Drug Administration (FDA) and other policymakers to adopt long-term sustainable solutions in addressing ...
This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. It's official. The drug industry's ...
President Donald Trump speaks about his new executive order demanding that pharmaceutical companies stop charging more in the U.S. than they do abroad for the same drugs: PRESIDENT DONALD TRUMP: I’m ...
The drug industry’s powerful Washington lobby is expected to pick a medical device executive as its next CEO. Steve Ubl, currently the head of the medical device manufacturer trade group AdvaMed, will ...
LONDON (Reuters) -AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging in advocacy at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results